Sanofi-Aventis U.S. LLC et al v. Hetero USA Inc. et al > Summary
Court Case Number 1:17-cv-00031
Filing Date Jan 11, 2017
Termination Date Mar 10, 2017
Court Delaware District Court
Status Dismissed - Voluntarily
JudgesGregory M. Sleet
Plaintiff Attorneys
13Aventisub LLC
Attorney Name: Jeffrey B. Bove
Buchanan Ingersoll & Rooney PC
Sanofi
Attorney Name: Jeffrey B. Bove
Buchanan Ingersoll & Rooney PC
Aventisub LLC
Attorney Name: Karen Riesenburger Poppel
Buchanan Ingersoll & Rooney PC
Sanofi
Attorney Name: Karen Riesenburger Poppel
Buchanan Ingersoll & Rooney PC
Aventisub LLC
Attorney Name: Paul H. Berghoff
McDonnell Boehnen Hulbert & Berghoff LLP
Aventisub LLC
Attorney Name: Alison J. Baldwin
McDonnell Boehnen Hulbert & Berghoff LLP
Aventisub LLC
Attorney Name: Paula S. Fritsch
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi Genzyme
Attorney Name: Paul H. Berghoff
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi
Attorney Name: Paul H. Berghoff
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi Genzyme
Attorney Name: Alison J. Baldwin
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi
Attorney Name: Alison J. Baldwin
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi
Attorney Name: Paula S. Fritsch
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi Genzyme
Attorney Name: Paula S. Fritsch
McDonnell Boehnen Hulbert & Berghoff LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09186346 | Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients | Nov 17, 2015 |
| 08802735 | (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability | Aug 12, 2014 |
| 06794410 | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4-trifluoromethylphenyl)-amide for treating multiple sclerosis | Sep 21, 2004 |
